224 related articles for article (PubMed ID: 6334934)
21. Paracortical activity in the lymph nodes draining female breast carcinoma.
Syrjänen KJ
Neoplasma; 1979; 26(1):95-102. PubMed ID: 311901
[TBL] [Abstract][Full Text] [Related]
22. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
[TBL] [Abstract][Full Text] [Related]
23. Significance of intramammary lymph nodes in the staging of breast cancer: correlation with tumor characteristics and outcome.
Nassar A; Cohen C; Cotsonis G; Carlson G
Breast J; 2008; 14(2):147-52. PubMed ID: 18248563
[TBL] [Abstract][Full Text] [Related]
24. [The reactivity of the regional lymph nodes and tumor stroma in cervix uteri cancer].
Raĭchev I; Raĭchev S
Akush Ginekol (Sofiia); 1993; 32(1):25-8. PubMed ID: 8172342
[TBL] [Abstract][Full Text] [Related]
25. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
[TBL] [Abstract][Full Text] [Related]
26. Identification and importance of lymphocyte subpopulations in the regional lymph nodes of breast cancer patients.
Khuri N; Jothy SP; Shibata HR
Can J Surg; 1989 Jan; 32(1):23-6. PubMed ID: 2463069
[TBL] [Abstract][Full Text] [Related]
27. [Prognostic significance of immunocompetent cell infiltration of breast tumor tissue].
Perel'muter VM; Slonimskaia EM; Cherdyntseva NV; Afrimson EA
Vopr Onkol; 1997; 43(6):596-8. PubMed ID: 9479358
[TBL] [Abstract][Full Text] [Related]
28. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
29. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].
Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207
[TBL] [Abstract][Full Text] [Related]
30. [Regional lymph nodes and mortality in breast cancer].
Spirina NV; Ivinskaia NV
Sov Med; 1989; (4):123. PubMed ID: 2788307
[No Abstract] [Full Text] [Related]
31. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
[TBL] [Abstract][Full Text] [Related]
32. [Histochemical study of the immune response of the regional lymph nodes in breast and stomach cancer].
Rudnitskaia AIu; Gnatyshak OP; Protopopov AA
Vopr Onkol; 1980; 26(9):41-5. PubMed ID: 6968474
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
Machiavelli MR; Romero AO; Pérez JE; Lacava JA; Domínguez ME; Rodríguez R; Barbieri MR; Romero Acuña LA; Romero Acuña JM; Langhi MJ; Amato S; Ortiz EH; Vallejo CT; Leone BA
Cancer J Sci Am; 1998; 4(2):125-31. PubMed ID: 9554929
[TBL] [Abstract][Full Text] [Related]
34. [Exploration of the extent of axillary dissection for patients with node positive primary breast cancer].
Ouyang T; Li JF; Wang TF; Lin BY
Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(5):298-300. PubMed ID: 15842936
[TBL] [Abstract][Full Text] [Related]
35. Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy?
Specht MC; Fey JV; Borgen PI; Cody HS
J Am Coll Surg; 2005 Jan; 200(1):10-4. PubMed ID: 15631914
[TBL] [Abstract][Full Text] [Related]
36. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
[TBL] [Abstract][Full Text] [Related]
37. Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up.
Reed W; Bøhler PJ; Sandstad B; Nesland JM
Breast J; 2004; 10(3):174-80. PubMed ID: 15125740
[TBL] [Abstract][Full Text] [Related]
38. Axillary lymph node metastases associated with small invasive breast carcinomas.
Maibenco DC; Weiss LK; Pawlish KS; Severson RK
Cancer; 1999 Apr; 85(7):1530-6. PubMed ID: 10193943
[TBL] [Abstract][Full Text] [Related]
39. Stages of development of immunologic response in the regional lymph nodes in invasive cancer of the uterine cervix.
Kozlowski H; Hrabowska M
Arch Geschwulstforsch; 1977; 47(6):550-60. PubMed ID: 607906
[TBL] [Abstract][Full Text] [Related]
40. Breast carcinoma grading, estimation of tumor size, axillary lymph node status, staging, and nottingham prognostic index scoring on mastectomy specimens.
Ahmad Z; Khurshid A; Qureshi A; Idress R; Asghar N; Kayani N
Indian J Pathol Microbiol; 2009; 52(4):477-81. PubMed ID: 19805950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]